Editorial commentary: Imminent challenges: Carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancy

Clinical Infectious Diseases

Volumn 58, Issue 9, 2014, Pages 1284-1286

  Johnson, Katherine ^a   Boucher, Helen W ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

carbapenem resistant Enterobacteriaceae; hematologic malignancy; solid organ transplant

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AVIBACTAM; CARBAPENEM; CARBAPENEMASE; CEPHALOSPORIN; DORIPENEM; FOSFOMYCIN; PLAZOMICIN; POLYMYXIN; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BLOODSTREAM INFECTION; DRUG EXPOSURE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HUMAN; HYDROLYSIS; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; INFECTION CONTROL; INFECTION PREVENTION; KLEBSIELLA PNEUMONIAE; MONOTHERAPY; NOTE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; URINARY TRACT INFECTION; COMPLICATION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; HEMATOLOGIC DISEASE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; TRANSPLANT RECIPIENTS;

EID: 84898899085     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu056     Document Type: Note

References (12)

1. Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-reistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis 2014; 58:1274-83
2. Mlynarczyk G, Kosykowska E, deWalthoffen SW, et al. A threat of the Klebsiella pneumoniae carbapenemase-producing strains among transplant recipients. Transplant Proc 2011; 43:3135-6
3. Centers for Disease Control and Prevention. 2012 CRE toolkit-guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). Available at: Http://www.cdc.gov/hai/ pdfs/cre/CRE-guidance-508.pdf. Accessed 5 January 2014
4. Marchaim D, Chopra T, Bhargava A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: The role of antimicrobial stewardship. Infect Control Hosp Epidemiol 2012; 33:817-30
5. Aitken SL, Palmer HR, Topal JE, Gabardi S, Tichy E. Call for antimicrobial stewardship in solid organ transplantation. Am J Transplant 2013; 13:2499
6. Tverdek FP, Rolston KV, Chemaly RF. Antimicrobial stewardship in patients with cancer. Pharmacotherapy 2012; 32:722-34
7. Bulik CC, Nicolau DP. Double-carbapenem therapy for carbapenemase- producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2011; 55:3002-4
8. Bulik CC, Nicolau DP. In vivo efficacy of simulated human dosing regimens of prolonged-infusion doripenem against carbapenemase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2010; 54: 4112-5
9. Perez F, Van Duin D. Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients. Cleve Clin J Med 2013; 80:225-33
10. Boucher HW, Talbot GH, Benjamin DK Jr, et al. 10 x '20 progress - development of new drugs active against gram-negative bacilli: An update from the Infectious Diseases Society of America. Clin Infect Dis 2013; 56:1685-94
11. Spellberg B, Bartlett JG, Gilbert DN. The future of antibiotics and resistance. N Engl J Med 2013; 368:299-302
12. Bartlett JG. When bacteria can no longer be stopped; adopt a national plan, like Europe's program. Available at: Http://www.nytimes. com/roomfordebate/2013/12/29/avoiding-Atime-when-bacteria-can-no-longer-be- stopped. Accessed 6 January 2014.